Want to buy for someone else? You can purchase a token at check out.
Overview
The course will be discontinued on April 15, 2019. Please plan to finish the course by April 14th if you wish to earn credit for it.
Around 600,000 new or recurrent cases of venous thromboembolism, a term that includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occur in the United States annually. As many as 25% of patients with a pulmonary embolus die of a sudden death with no previous symptoms. Thirty-day survival rates for DVT are as high as 94.5% although if pulmonary embolus is present, with or without a DVT, the survival rate decreases to 55.6%. Venous thromboembolism contributes to between 100,000 and 180,000 deaths annually. It's probable that more cases occur but remain undiagnosed. In a variety of settings, healthcare professionals are likely to encounter patients with or at risk for venous thromboembolism. They should understand and educate patients about the risk factors for this potentially fatal, but largely preventable, disorder.
Goals and Learning Outcomes
- List the triad of risk factors for venous thromboembolism
- Identify four preventive measures for DVT
- Describe two therapeutic interventions each for DVT and pulmonary embolism
Course Details
Course Originally Released on : 5/23/2005
CE366-60
Course Author
MSN, AGACNP-BC, CCRN, CNRN
MPA, RN
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.